The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time to subsequent therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) receiving dostarlimab plus carboplatin-paclitaxel (DOST+CP) compared with pts receiving placebo plus CP (PBO+CP) in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial.
 
Cara Mathews
Research Funding - AADI (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); avenge bio (Inst); Deciphera (Inst); Elucida Oncology (Inst); EMD Serono (Inst); Genmab (Inst); Immunogen (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro/GSK (Inst); Volastra Therapeutics (Inst); Zentalis (Inst)
 
Nicoline Raashouu-Jensen
Honoraria - MSD
Travel, Accommodations, Expenses - MSD
 
Carolyn McCourt
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Filip Frühauf
No Relationships to Disclose
 
Lucy Gilbert
Honoraria - GlaxoSmithKline; Merck; Repare Therapeutics
Consulting or Advisory Role - Corcept Therapeutics; Eisai; GlaxoSmithKline; Immunogen; Kora Healthcare; Merck
Research Funding - Alkermes (Inst); Ascendis Pharma (Inst); AstraZeneca (Inst); Corcept Therapeutics (Inst); Esperas Pharma (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Immunogen (Inst); IMV (Inst); K-Group Beta (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Mersana (Inst); Novocure (Inst); OncoQuest (Inst); Repare Therapeutics (Inst); Roche (Inst); Seagen (Inst); Shattuck Labs (Inst); Sutro BioPharma Inc (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Corcept Therapeutics; Eisai; EndomEra; GlaxoSmithKline; GOG Foundation; Merck; Zentalis
 
Evelyn Fleming
No Relationships to Disclose
 
Giorgio Valabrega
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; MSD
Consulting or Advisory Role - Eisai; GlaxoSmithKline
Travel, Accommodations, Expenses - MSD
 
Noelle Cloven
Consulting or Advisory Role - Abbvie; Genmab; GlaxoSmithKline; Toray Industries
 
Dominik Denschlag
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Intuitive Surgical; KLS Martin Group; MSD
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Intuitive Surgical; KLS Martin Group; PharmaMar; Seagen/Pfizer
Speakers' Bureau - AstraZeneca; Eisai; GlaxoSmithKline; Intuitive Surgical; KLS Martin Group; MSD
Travel, Accommodations, Expenses - AstraZeneca
 
Iwona Podzielinski
No Relationships to Disclose
 
Ingrid Boere
Consulting or Advisory Role - AstraZeneca (Inst)
 
Joseph Buscema
Employment - Arizona Oncology
Leadership - Arizona Oncology
Stock and Other Ownership Interests - McKesson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Caris Life Sciences; GlaxoSmithKline
 
Kathryn Pennington
No Relationships to Disclose
 
Nicole Nevadunsky
Honoraria - Blueprint Medicines
Consulting or Advisory Role - LEK; LEK
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Pfizer (Inst); Tesaro (Inst); Tesaro (Inst)
 
Eirwen Miller
Consulting or Advisory Role - AstraZeneca
 
Mark Shahin
Honoraria - AstraZeneca; eisai; genmab; GlaxoSmithKline; Immunogen; Seagen
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Immunogen; Merck
Speakers' Bureau - AstraZeneca; Eisai; Genmab; GlaxoSmithKline; seagen
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Unite For Her
 
Grace Antony
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Laura Austin
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Matthew Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline/Tesaro; GOG partners; Immunogen; Merck; Seagen; Tesaro
Research Funding - GlaxoSmithKline/Tesaro (Inst)
 
Mansoor Mirza
Leadership - Karyopharm Therapeutics; Sera Prognostics
Stock and Other Ownership Interests - Karyopharm Therapeutics; Sera Prognostics
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Takeda; Zai Lab
Consulting or Advisory Role - Abbvie; Allarity Therapeutics; AstraZeneca; BIOCAD; BioNTech; Daiichi Sankyo; Eisai; Genmab; GlaxoSmithKline; ImmunoGen/AbbVie; Incyte; Karyopharm Therapeutics; MSD; Regeneron; Zai Lab
Speakers' Bureau - AstraZeneca; Eisai; GlaxoSmithKline; Takeda; Zai Lab
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline